Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives

Lalitha Simon, Abdul Ajees Abdul Salam, S. Madan Kumar, T. Shilpa, K. K. Srinivasan, K. Byrappa

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)


A series of 3-Benzylchroman-4-ones were synthesized and screened for anticancer activity by MTT assay. The compounds were evaluated against two cancerous cell lines BT549 (human breast carcinoma), HeLa (human cervical carcinoma), and one noncancerous cell line vero (normal kidney epithelial cells). 3b was found to be the most active molecule against BT549 cells (IC50 = 20.1 µM) and 3h against HeLa cells (IC50 = 20.45 µM). 3b also exhibited moderate activity against HeLa cells (IC50 = 42.8 µM). The molecular structures of 3h and 3i were solved by single crystal X-ray crystallographic technique. Additionally, the molecular docking studies between the tumour suppressor protein p53 with the lead compound 3h, which exhibited better anticancer activity against HeLa cells was examined.

Original languageEnglish
Pages (from-to)5284-5290
Number of pages7
JournalBioorganic and Medicinal Chemistry Letters
Issue number23
Publication statusPublished - 01-12-2017

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry


Dive into the research topics of 'Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives'. Together they form a unique fingerprint.

Cite this